External validation of a 'response score' after neoadjuvant chemotherapy in patients with high-grade serous ovarian carcinoma with complete clinical response
External validation of a 'response score' after neoadjuvant chemotherapy in patients with high-grade serous ovarian carcinoma with complete clinical response
(2020)
Autori:
Zorzato, Pier Carlo; Zannoni, Gian Franco; Tudisco, Riccardo; Pasciuto, Tina; Di Giorgio, Andrea; Franchi, Massimo; Scambia, Giovanni; Fagotti, Anna
Titolo:
External validation of a 'response score' after neoadjuvant chemotherapy in patients with high-grade serous ovarian carcinoma with complete clinical response
The chemotherapy response score (CRS) has been developed for measuring response to neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma. This study aimed to validate the ability of this three-tier scoring system of pathologic response on omental specimens to determine prognosis in a subgroups of patients who had clinical complete response to neoadjuvant chemotherapy.
Id prodotto:
111473
Handle IRIS:
11562/1008344
ultima modifica:
15 novembre 2022
Citazione bibliografica:
Zorzato, Pier Carlo; Zannoni, Gian Franco; Tudisco, Riccardo; Pasciuto, Tina; Di Giorgio, Andrea; Franchi, Massimo; Scambia, Giovanni; Fagotti, Anna,
External validation of a 'response score' after neoadjuvant chemotherapy in patients with high-grade serous ovarian carcinoma with complete clinical response«International Journal of Gynecological Cancer»
, 2020
, pp. 67-73